Finance

Lists
Why is 373110 down 4.16%?
Dive Deeper
373110:KOSDAQ
Xcell Therapeutics Inc
₩715.00
-4.16%
(-31.00) 1D
Nov 18, 11:19:52 AM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 373110...
Open
₩747
High
₩772
Low
₩707
Mkt. cap
12.37B
Avg. vol.
76.19K
Volume
25.37K
52-wk high
₩2,125
52-wk low
₩707
EPS
-₩980
Shares outstanding
17.29M
No. of employees
63
Open
₩747
High
₩772
Low
₩707
Mkt. cap
12.37B
Avg. vol.
76.19K
Volume
25.37K
52-wk high
₩2,125
52-wk low
₩707
EPS
-₩980
Shares outstanding
17.29M
No. of employees
63
News stories
From web sources and news partners
ING Sprinters
ING Sprinters
·
7 hours ago
De AEX Index breekt steun
ZeelandNet, startpagina van Zeeland
ZeelandNet, startpagina van Zeeland
·
7 hours ago
AEX-index lager, chipbedrijven dalen in aanloop cijfers Nvidia
About Xcell Therapeutics Inc
CEO-
Employees63
Founded2015
Headquarters-
SectorHealth Care
IndustryBiotechnology
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
334.59M
1.06B
1.02B
1.94B
Cost of goods sold
561.08M
2.12B
1.08B
2.49B
Cost of revenue
561.08M
2.12B
1.08B
2.49B
Research and development expenses
611.41M
756.15M
1.20B
329.84M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.45B
1.24B
1.43B
1.59B
Operating expense
2.15B
2.20B
2.85B
2.20B
Total operating expenses
2.71B
4.32B
3.94B
4.69B
Operating income
-2.38B
-3.26B
-2.91B
-2.75B
Other non operating income
20.42M
-353.29M
-69.76M
-171.24M
EBT including unusual items
-2.31B
-3.36B
-2.93B
-2.83B
EBT excluding unusual items
-2.40B
-3.39B
-2.92B
-2.86B
Income tax expense
-
-
-
-65.48M
Effective tax rate
-
-
-
2.32%
Other operating expenses
6.23M
14.99M
22.99M
8.22M
Net income
-2.31B
-3.36B
-2.93B
-2.76B
Net profit margin
-690.49%
-316.40%
-286.74%
-142.56%
Earnings per share
-
-
-
-
Interest and investment income
19.10M
214.66M
63.08M
45.36M
Interest expense
-67.34M
-
-610.00K
-622.00K
Net interest expenses
-48.24M
214.66M
62.47M
44.74M
Depreciation and amortization charges
157.34M
155.88M
157.92M
145.62M
EBITDA
-1.95B
-2.84B
-2.51B
-2.36B
Gain or loss from assets sale
-85.09M
-13.57M
-
-
Upcoming events
AI content may include mistakes. Learn more
Google apps